A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia

Journal of the National Cancer Institute

Volumn 94, Issue 13, 2002, Pages 1001-1009

  Lam, Stephen ^a,e   MacAulay, Calum ^a   Le Riche, Jean C ^a   Dyachkova, Yulia ^a   Coldman, Andy ^a   Guillaud, Martial ^a   Hawk, Ernest ^b   Christen, Marie Odile ^c   Gazdar, Adi F ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Solvay Pharma   (France)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANETHOLE TRITHIONE; BIOLOGICAL MARKER; OLTIPRAZ; ORGANOSULFUR DERIVATIVE; PLACEBO;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER PREVENTION; CELL NUCLEUS; CHEMOPROPHYLAXIS; CHI SQUARE TEST; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FLATULENCE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG CANCER; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVATION; SIDE EFFECT; SMOKING; STATISTICAL ANALYSIS;

EID: 0037014797     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.13.1001     Document Type: Article

References (40)

1. Cancer statistics, 2001
2. Patterns of absolute risk of lung cancer mortality in former smokers
3. Lung carcinoma in former smokers
4. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)
5. Recent advances in chemoprevention of cancer
6. Chemoprotection by Oltipraz and other dithiolethiones
7. Chemoprevention of colon carcinogenesis by organosulfur compounds
8. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1, 2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones
9. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis
10. Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone in A/J mouse lung
11. Phase I/pharmacodynamic study of N-acetylcysteine/ oltipraz in smokers: Early termination due to excessive toxicity
12. Clinical aspects of xerostomia
13. Effect of Sialor in treatment of xerostomia in Sjogren's syndrome
14. Approaches to the development and marketing approval of drugs that prevent cancer
15. Sputum screening by quantitative microscopy: A reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study
16. Cyto-Savant™ and its use in automated screening of cervical smears
17. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy
18. Sex-related differences in bronchial epithelial changes associated with tobacco smoking
19. Histologic and graphical text slides for the histological typing of lung and pleural tumors
20. Endoscopic localization of preneoplastic lung lesions
21. Nuclear texture measurements in image cytometry
22. Sputum cytopathology: Use and potential in monitoring the workplace environment by screening for biological effects of exposure
23. Carcinoma in situ of the lung: Its development, detection, and treatment
24. Diagnostic significance of "severe dysplasia" in sputum cytology
25. Pathogenesis of epidermoid carcinoma of lung
26. Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy
27. A follow up study of squamous dysplasia
28. Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy
29. Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents
30. Cytological studies in man and animals on development of bronchogenic carcinoma
31. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia
32. N-(4-hydroxyphenyl) retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium
33. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer
34. Protective effect of anethol dithiolthione against acetaminophen hepatotoxicity in mice
35. Anethole dithiolethione: Biochemical considerations
36. Anethole dithiolethione: Research overview and perspectives
37. Inhibition of NF-kappa B activation in human T-cell lines by anetholdithiolthione
38. Protective effects of anetholedithiolthione against oxidative stress-induced cytotoxicity in human Jurkat T cells
39. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China
40. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation